Furgiuele A - Search Results

1

Polymorphisms of Dopamine Receptor Genes and Parkinson's Disease: Clinical Relevance and Future Perspectives.

Magistrelli L, Ferrari M, Furgiuele A, Milner AV, Contaldi E, Comi C, Cosentino M, Marino F. Magistrelli L, et al. Among authors: furgiuele a. Int J Mol Sci. 2021 Apr 6;22(7):3781. doi: 10.3390/ijms22073781. Int J Mol Sci. 2021. PMID: 33917417 Free PMC article. Review.

2

Immunomodulatory Potential of Cannabidiol in Multiple Sclerosis: a Systematic Review.

Furgiuele A, Cosentino M, Ferrari M, Marino F. Furgiuele A, et al. J Neuroimmune Pharmacol. 2021 Jun;16(2):251-269. doi: 10.1007/s11481-021-09982-7. Epub 2021 Jan 25. J Neuroimmune Pharmacol. 2021. PMID: 33492630 Free PMC article.

3

Relationship between [¹²³I]FP-CIT SPECT data and peripheral CD4 + T cell profile in newly-diagnosed drug-naïve Parkinson's disease patients.

Contaldi E, Magistrelli L, Furgiuele A, Gallo S, Comi C. Contaldi E, et al. Among authors: furgiuele a. J Neurol. 2023 May;270(5):2776-2783. doi: 10.1007/s00415-023-11635-z. Epub 2023 Feb 25. J Neurol. 2023. PMID: 36840790

4

Dopaminergic regulation of inflammation and immunity in Parkinson's disease: friend or foe?

Furgiuele A, Pereira FC, Martini S, Marino F, Cosentino M. Furgiuele A, et al. Clin Transl Immunology. 2023 Sep 29;12(10):e1469. doi: 10.1002/cti2.1469. eCollection 2023. Clin Transl Immunology. 2023. PMID: 37781343 Free PMC article. Review.

5

Effect of Cannabidiol on Human Peripheral Blood Mononuclear Cells and CD4+ T Cells.

Furgiuele A, Marino F, Rasini E, Legnaro M, Luini A, Albizzati MG, di Flora A, Pacchetti B, Cosentino M. Furgiuele A, et al. Int J Mol Sci. 2023 Oct 4;24(19):14880. doi: 10.3390/ijms241914880. Int J Mol Sci. 2023. PMID: 37834328 Free PMC article.

6

A peripheral blood mononuclear cell-based in vitro model: A tool to explore indoleamine 2, 3-dioxygenase-1 (IDO1).

Gonçalves M, Furgiuele A, Rasini E, Legnaro M, Ferrari M, Luini A, Rodrigues-Santos P, Caramelo F, Marino F, Pereira FC, Cosentino M. Gonçalves M, et al. Among authors: furgiuele a. Eur J Pharmacol. 2024 Apr 5;968:176420. doi: 10.1016/j.ejphar.2024.176420. Epub 2024 Feb 16. Eur J Pharmacol. 2024. PMID: 38367683 Free article.

7

Pharmacology of kava. 2.

Buckley JP, Furgiuele AR, O'Hara MJ. Buckley JP, et al. Among authors: furgiuele ar. Psychopharmacol Bull. 1967 Dec;4(3):11-2. Psychopharmacol Bull. 1967. PMID: 5616310 No abstract available.

8

Comparative central activities of a new dihydrodibenzoxazepine antihistaminic and of pyrilamine.

Furgiuele AR, High JP, Horovitz ZP, Burke JC. Furgiuele AR, et al. Arch Int Pharmacodyn Ther. 1966 Mar;160(1):4-13. Arch Int Pharmacodyn Ther. 1966. PMID: 4381241 No abstract available.

9

Appetite suppression due to alpha-methyl-m-tyrosine.

Carlton PL, Furgiuele AR. Carlton PL, et al. Among authors: furgiuele ar. Life Sci. 1965 May;4(10):1099-106. doi: 10.1016/0024-3205(65)90230-4. Life Sci. 1965. PMID: 5838512 No abstract available.

10

Some central effects of SQ 10,643 [2'3-(-dimethlaminopropylthio) cinnamanilide hydrochloride], a potent serotonin antagonist.

Furgiuele AR, High JP, Horovitz ZP. Furgiuele AR, et al. Arch Int Pharmacodyn Ther. 1965 May;155(1):225-35. Arch Int Pharmacodyn Ther. 1965. PMID: 5834938 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

17 results

Search Page